Journal profile · Medicine-Psychiatry and Mental Health

The journal of prevention of Alzheimer's disease

ISSN 2426-0266 · Springer Nature · 4 issues per year

The journal of prevention of Alzheimer's disease: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 6.7 (journal website); fully open access; APC about USD 4,060; median 87 days to acceptance (85 articles, last 24 months); 301 articles in 2025; indexed in Scopus.

Impact factor6.7From the journal's website, latest value
CAS zoneZone 3 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 3 · Medicine
Review time87 daysMedian, submission to acceptance · 85 articles, last 24 months · PubMed
APCUSD 4,060Fully open access
Acceptance—No reports yet
Articles per year3012025 · OpenAlex count

Scope

Aims, scope and focus

The journal of prevention of Alzheimer's disease is published by Springer Nature and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments and Nutritional Studies and Diet, together about 60.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

The Journal of Prevention of Alzheimer’s Disease (JPAD) is an e-only Gold Open Access journal that publishes reviews, original research articles and short reports to improve the knowledge in the field of Alzheimer's Disease prevention including: neurosciences, biomarkers, imaging, epidemiology, public health, physical cognitive exercise, nutrition, risk and protective factors, drug development, trials design, and health economics outcomes.JPAD publishes also the meeting abstracts from the Clinical Trial on Alzheimer's Disease (CTAD) Conference.The Journal of Prevention of Alzheimer’s Disease is indexed in MEDLINE, SCIE (WoS), Scopus, and ranked in its categories in the first quartile (Q1) in both SCIE (WoS) and Scopus databases.

From the journal's Aims & Scope

Research area (LetPub): Medicine-Psychiatry and Mental Health

Editor-in-chief Paul AisenPublisher website

Editorial board by country: 2 in mainland China (about 2%); most named United States 54, France 11, Spain 7, Sweden 3, Mainland China 2 (97 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Dementia and Cognitive Impairment ResearchMedicine34.3%
  2. Alzheimer's disease research and treatmentsMedicine21.5%
  3. Nutritional Studies and DietMedicine4.4%
  4. Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance4.1%
  5. Cancer-related cognitive impairment studiesMedicine3%
  6. Health, Environment, Cognitive AgingEnvironmental Science2.6%
  7. Frailty in Older AdultsMedicine2.5%
  8. Neurological Disease Mechanisms and TreatmentsNeuroscience2.5%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorClinical NeurologyZone 3

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorClinical NeurologyZone 3

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorClinical NeurologyZone 3

Top journal: noReview journal: no

Database indexing

ScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

SCIEMEDLINEPublisher website

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor (publisher)
6.7Publisher website ·
CiteScore 2026-06
10.4LetPub ·
CiteScore (publisher)
10.4Publisher website ·
SJR 2026-06
2.27LetPub ·
SNIP 2026-06
1.52LetPub ·
h-index
63OpenAlex ·
i10-index
504OpenAlex ·
2-year mean citedness
6.66OpenAlex ·
Share of gold OA articles
0%LetPub ·

Articles by year OpenAlex count · 1,324 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026216216200
20253013012,284
20241701702,092
20231331333,109
20221091093,709
202195954,308

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

87 daysMedian, submission to acceptance · P25–P75 64 days – 135 days

Acceptance to online
median 14 days (85 articles)
Submission to online
median 106 days
Sample
85 articles with submission and acceptance dates (474 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Submission to first decision
6 daysPublisher website ·
First decision after review
31 daysPublisher website ·
Submission to acceptance
64 daysPublisher website ·
Submission to publication (journal-reported)
about 20 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJUSD 4,060YesCC BY, CC BY-NC-ND
OpenAlexUSD 4,060 / EUR 3,800 / GBP 3,250 / JPY 503,560——
Publisher websiteUSD 4,060——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Article types accepted14
  1. book reviewJPAD - The Journal of Prevention of Alzheimer’s Disease publishes Original Papers, Reviews, Brief Reports, Editorials, Letters to the Editor, and Book Reviews. …Length not stated
  2. book reviewsJPAD - The Journal of Prevention of Alzheimer’s Disease publishes Original Papers, Reviews, Brief Reports, Editorials, Letters to the Editor, and Book Reviews.Length not stated
  3. brief reportJPAD - The Journal of Prevention of Alzheimer’s Disease publishes Original Papers, Reviews, Brief Reports, Editorials, Letters to the Editor, and Book Reviews. …Length not stated
  4. brief reportsJPAD - The Journal of Prevention of Alzheimer’s Disease publishes Original Papers, Reviews, Brief Reports, Editorials, Letters to the Editor, and Book Reviews.Length not stated
  5. commentaryJPAD - The Journal of Prevention of Alzheimer’s Disease publishes Original Papers, Reviews, Brief Reports, Editorials, Letters to the Editor, and Book Reviews. …Length not stated
  6. editorialJPAD - The Journal of Prevention of Alzheimer’s Disease publishes Original Papers, Reviews, Brief Reports, Editorials, Letters to the Editor, and Book Reviews. …Length not stated
  7. editorialsJPAD - The Journal of Prevention of Alzheimer’s Disease publishes Original Papers, Reviews, Brief Reports, Editorials, Letters to the Editor, and Book Reviews.Length not stated
  8. letters to the editorJPAD - The Journal of Prevention of Alzheimer’s Disease publishes Original Papers, Reviews, Brief Reports, Editorials, Letters to the Editor, and Book Reviews. …Length not stated
  9. original articleJPAD - The Journal of Prevention of Alzheimer’s Disease publishes Original Papers, Reviews, Brief Reports, Editorials, Letters to the Editor, and Book Reviews. …Length not stated
  10. original paperJPAD - The Journal of Prevention of Alzheimer’s Disease publishes Original Papers, Reviews, Brief Reports, Editorials, Letters to the Editor, and Book Reviews. …Length not stated
  11. original papersJPAD - The Journal of Prevention of Alzheimer’s Disease publishes Original Papers, Reviews, Brief Reports, Editorials, Letters to the Editor, and Book Reviews.Length not stated
  12. reviewJPAD - The Journal of Prevention of Alzheimer’s Disease publishes Original Papers, Reviews, Brief Reports, Editorials, Letters to the Editor, and Book Reviews. …Length not stated
  13. review articleJPAD - The Journal of Prevention of Alzheimer’s Disease publishes Original Papers, Reviews, Brief Reports, Editorials, Letters to the Editor, and Book Reviews. …Length not stated
  14. reviewsJPAD - The Journal of Prevention of Alzheimer’s Disease publishes Original Papers, Reviews, Brief Reports, Editorials, Letters to the Editor, and Book Reviews.Length not stated
Publisher website
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
AI use Declaration of generative AI use

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

Source ↗Publisher website ·
Authorship Authorship

By adhering to the authorship requirements stated above, authors meet the International Committee of Medical Journal Editors (ICMJE) criteria [updated version January 2024] on authorship.

Source ↗Publisher website ·
Conflicts of interest Declaration of competing interests

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …

Source ↗Publisher website ·
License & copyright License options

Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.

Source ↗Publisher website ·
Open access Open access

We refer you to our open access information page to learn about open access options for this journal.

Source ↗Publisher website ·
Peer review Peer review

Single anonymized review process Model summary

This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…

Source ↗Publisher website ·
Preprints Preprints

Preprint sharing allowed Model summary

Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Springer Nature
Frequency
4 issues per year
ISSN
2426-0266
Print ISSN
2274-5807
Official links

FAQ

Frequently asked questions about The journal of prevention of Alzheimer's disease

What CAS zone is The journal of prevention of Alzheimer's disease in?

In the 2025 upgraded edition of the CAS Journal Ranking, The journal of prevention of Alzheimer's disease is in Zone 3 of Medicine, and in Zone 3 of the minor category Clinical Neurology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of The journal of prevention of Alzheimer's disease?

The journal's website gives an impact factor of 6.7; this is the journal's own figure, as LetPub lists none for it; CiteScore 10.4, h-index 63.

How long does peer review take at The journal of prevention of Alzheimer's disease?

Based on the dates recorded on 85 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 87 days (interquartile range 64–135 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of The journal of prevention of Alzheimer's disease based?

Of the 97 board members whose country the journal's board page names, 2 (about 2%) are in mainland China; the countries named most often are United States (54), France (11) and Spain (7). Counted from the institutions listed on the board page; for reference only.

Which databases index The journal of prevention of Alzheimer's disease?

According to LetPub and DOAJ records, The journal of prevention of Alzheimer's disease is indexed in Scopus and DOAJ. The journal's website also lists SCIE and MEDLINE; that list has not been checked against each database.

Is The journal of prevention of Alzheimer's disease open access, and what is the APC?

The journal of prevention of Alzheimer's disease is a fully open-access journal. APC about USD 4,060.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .